常山药业
(300255)
| 流通市值：432.87亿 | | | 总市值：433.70亿 |
| 流通股本：9.17亿 | | | 总股本：9.19亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 217,802,209.12 | 280,796,134.44 | 236,440,111.55 | 314,222,871.16 |
| 应收票据及应收账款 | 332,322,337.02 | 329,202,299.89 | 255,518,934.25 | 267,751,748.26 |
| 其中：应收票据 | 273,076.97 | 2,213,074.97 | 1,893,602.2 | 1,625,000 |
| 应收账款 | 332,049,260.05 | 326,989,224.92 | 253,625,332.05 | 266,126,748.26 |
| 应收款项融资 | 4,146,950.81 | 170,000 | 10,221,496.57 | 12,643,759.71 |
| 预付款项 | 106,215,842.69 | 65,957,874.23 | 51,135,286.5 | 130,255,840.55 |
| 其他应收款合计 | 18,884,731.41 | 11,103,941.37 | 11,454,991.27 | 18,812,009.27 |
| 存货 | 1,259,420,280.67 | 1,287,938,950.74 | 1,385,747,770.05 | 1,448,016,763.76 |
| 其他流动资产 | 45,256,557.73 | 36,852,013.19 | 51,894,041.29 | 48,773,225.91 |
| 流动资产合计 | 1,984,048,909.45 | 2,012,021,213.86 | 2,002,412,631.48 | 2,240,476,218.62 |
| 非流动资产: | | | | |
| 长期应收款 | 7,500,000 | 7,500,000 | 7,500,000 | 7,500,000 |
| 投资性房地产 | 2,995,731.19 | 2,278,307.71 | 3,050,531.17 | 3,050,531.17 |
| 固定资产 | 972,333,497.72 | 986,908,320.86 | 998,055,221.39 | 992,975,606.05 |
| 在建工程 | 747,971,397.37 | 727,199,414.63 | 708,968,785.87 | 679,909,062.73 |
| 使用权资产 | 4,797,130.51 | 5,790,976.15 | 6,390,160.91 | 1,413,703.8 |
| 无形资产 | 306,508,246.38 | 306,010,523.3 | 308,133,361.7 | 312,520,485.54 |
| 开发支出 | 449,700,214.54 | 433,439,929.52 | 427,857,914.68 | 405,104,984.75 |
| 长期待摊费用 | 4,044,220.01 | 2,185,074.59 | 4,725,450.14 | 1,404,210.89 |
| 递延所得税资产 | 18,794,593.48 | 20,936,382.84 | 21,894,490.82 | 18,656,989.83 |
| 其他非流动资产 | 40,668,176.21 | 43,905,308.86 | 33,771,992.42 | 23,220,136.93 |
| 非流动资产合计 | 2,555,313,207.41 | 2,536,154,238.46 | 2,520,347,909.1 | 2,445,755,711.69 |
| 资产总计 | 4,539,362,116.86 | 4,548,175,452.32 | 4,522,760,540.58 | 4,686,231,930.31 |
| 流动负债: | | | | |
| 短期借款 | 1,120,214,868.61 | 1,075,228,250.55 | 887,546,719.51 | 876,643,157.61 |
| 应付票据及应付账款 | 431,543,168.51 | 306,614,850.01 | 307,465,026.08 | 307,887,097.54 |
| 其中：应付票据 | 86,943,869.71 | 42,220,435.22 | 42,278,218.64 | - |
| 应付账款 | 344,599,298.8 | 264,394,414.79 | 265,186,807.44 | 307,887,097.54 |
| 预收款项 | 10,870,994.75 | 10,911,351.68 | 11,590,374.69 | 16,240,651.23 |
| 合同负债 | 12,895,320.45 | 20,037,333.55 | 14,532,885.87 | 16,324,560.59 |
| 应付职工薪酬 | 26,080,647.32 | 28,257,808.43 | 27,279,984.82 | 28,658,803.92 |
| 应交税费 | 6,595,112.82 | 5,280,411.28 | 3,744,743.86 | 3,340,006.03 |
| 其他应付款合计 | 27,920,769.5 | 15,526,298.5 | 17,667,662.61 | 24,940,495.99 |
| 一年内到期的非流动负债 | 868,969,217.2 | 987,106,520.55 | 930,062,873.77 | 698,635,221.44 |
| 其他流动负债 | 1,833,788.53 | 1,126,897.41 | 2,902,721.58 | 1,751,345.6 |
| 流动负债合计 | 2,506,923,887.69 | 2,450,089,721.96 | 2,202,792,992.79 | 1,974,421,339.95 |
| 非流动负债: | | | | |
| 长期借款 | 435,819,558.55 | 445,849,579.52 | 659,474,271.57 | 764,910,500 |
| 租赁负债 | 2,174,191.5 | 3,860,697.75 | 3,911,509.19 | 1,539,053.37 |
| 长期应付款 | 36,176,609.22 | 48,482,804.7 | 60,530,188.59 | 126,783,814.77 |
| 递延收益 | 58,740,777.35 | 59,349,669.7 | 60,005,934.72 | 46,372,192.9 |
| 递延所得税负债 | 285,172.2 | 320,617.9 | 306,372.87 | 316,973.22 |
| 非流动负债合计 | 533,196,308.82 | 557,863,369.57 | 784,228,276.94 | 939,922,534.26 |
| 负债合计 | 3,040,120,196.51 | 3,007,953,091.53 | 2,987,021,269.73 | 2,914,343,874.21 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 919,060,878 | 919,060,878 | 919,060,878 | 919,060,878 |
| 资本公积 | 422,737,004.45 | 422,737,004.45 | 422,737,004.45 | 422,737,004.45 |
| 其他综合收益 | -330,955.82 | -128,353.64 | -54,202.67 | -131,235.11 |
| 盈余公积 | 185,639,365.56 | 185,639,365.56 | 185,639,365.56 | 185,639,365.56 |
| 未分配利润 | 5,786,688.04 | 38,658,250.66 | 34,875,641.49 | 291,643,459.17 |
| 归属于母公司股东权益合计 | 1,532,892,980.23 | 1,565,967,145.03 | 1,562,258,686.83 | 1,818,949,472.07 |
| 少数股东权益 | -33,651,059.88 | -25,744,784.24 | -26,519,415.98 | -47,061,415.97 |
| 股东权益合计 | 1,499,241,920.35 | 1,540,222,360.79 | 1,535,739,270.85 | 1,771,888,056.1 |
| 负债和股东权益合计 | 4,539,362,116.86 | 4,548,175,452.32 | 4,522,760,540.58 | 4,686,231,930.31 |
| 公告日期 | 2025-08-23 | 2025-04-29 | 2025-04-29 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |